These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21475661)
1. The Stakes in Bayh-Dole: Public Values Beyond the Pace of Innovation. Valdivia WD Minerva; 2011 Mar; 49(1):25-46. PubMed ID: 21475661 [TBL] [Abstract][Full Text] [Related]
2. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms. Sarpatwari A; Kesselheim AS; Cook-Deegan R J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952 [TBL] [Abstract][Full Text] [Related]
3. Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh-Dole Act. Silva PJ; Ramos KS Acad Med; 2018 Aug; 93(8):1135-1141. PubMed ID: 29668523 [TBL] [Abstract][Full Text] [Related]
4. COVID-IP: staring down the Bayh-Dole Act with 2020 vision. Paradise J J Law Biosci; 2020; 7(1):lsaa073. PubMed ID: 33033619 [TBL] [Abstract][Full Text] [Related]
5. NIH funding for patents that contribute to market exclusivity of drugs approved 2010-2019 and the public interest protections of Bayh-Dole. Ledley FD; Cleary EG PLoS One; 2023; 18(7):e0288447. PubMed ID: 37494368 [TBL] [Abstract][Full Text] [Related]
6. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study. Treasure CL; Avorn J; Kesselheim AS Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985 [TBL] [Abstract][Full Text] [Related]
8. MORE THAN MONEY: THE EXPONENTIAL IMPACT OF ACADEMIC TECHNOLOGY TRANSFER. McDevitt VL; Mendez-Hinds J; Winwood D; Nijhawan V; Sherer T; Ritter JF; Sanberg PR Technol Innov; 2014 Nov; 16(1):75-84. PubMed ID: 25061505 [TBL] [Abstract][Full Text] [Related]
9. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act. Berman EP Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798 [TBL] [Abstract][Full Text] [Related]
10. Patenting: the Bayh-Dole Act and its transformative impact on science innovation and commercialization. Miteu GD Ann Med Surg (Lond); 2024 Jun; 86(6):3192-3195. PubMed ID: 38846872 [No Abstract] [Full Text] [Related]
11. Intellectual property conundrum for the biological sciences. Olds JL Anat Rec B New Anat; 2004 Mar; 277(1):5-9. PubMed ID: 15052648 [TBL] [Abstract][Full Text] [Related]
12. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business. Fernandes M; Miska D Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036 [No Abstract] [Full Text] [Related]
13. Updating the Bayh-Dole Act: March-in Rights and Transparency. Cook-Deegan R; Kesselheim AS; Sarpatwari A JAMA; 2022 Mar; 327(10):923-924. PubMed ID: 35201276 [No Abstract] [Full Text] [Related]
14. Use the Bayh-Dole Act to lower drug prices for government healthcare programs. Engelberg AB; Kesselheim AS Nat Med; 2016 Jun; 22(6):576. PubMed ID: 27270771 [No Abstract] [Full Text] [Related]
15. Realizing Public Rights Through Government Patent Use. Kapczynski A J Law Med Ethics; 2021; 49(1):34-38. PubMed ID: 33966648 [TBL] [Abstract][Full Text] [Related]
16. The Bayh-Dole Act: a model for promoting research translation? Loewenberg S Mol Oncol; 2009 Apr; 3(2):91-3. PubMed ID: 19383372 [TBL] [Abstract][Full Text] [Related]
17. The Bayh-Dole Act, a lion without claws. Feldman AM Clin Transl Sci; 2015 Feb; 8(1):3-4. PubMed ID: 25675969 [No Abstract] [Full Text] [Related]
18. Bayh-Dole: almost 25. Kennedy D Science; 2005 Mar; 307(5714):1375. PubMed ID: 15746390 [No Abstract] [Full Text] [Related]
19. Patents, profits, and the American people--the Bayh-Dole Act of 1980. Markel H N Engl J Med; 2013 Aug; 369(9):794-6. PubMed ID: 23984726 [No Abstract] [Full Text] [Related]
20. Research and the Bayh-Dole Act. Reczek PR Science; 2004 Jan; 303(5654):40. PubMed ID: 14704412 [No Abstract] [Full Text] [Related] [Next] [New Search]